Transferrin saturation ≤20% was highest in patients with stage 5 CKD (stage 1: 41.2%; stage 2: 20.0%; stage 3: 42.3%; stage 4: 36.2%; stage 5: 43.4%). The gene discussed is TF; the disease is chronic kidney disease.